1214 Palladian Way
16 articles about NIH
Aqualung Therapeutics Corporation Receives A $1.7 Million National Institute Of Health (NIH) Fastrack Award To Develop An Novel Immune-Based Therapeutic Antibody For Critically Ill Patients With Acute Lung Injury
Aqualung scientists identified nicotinamide phosphoribosyltransferase as a novel upstream immune-based therapeutic target in the development of Acute Respiratory Distress Syndrome, their lead clinical indication. They have developed eNamptor™, a humanized monoclonal antibody designed to neutralize circulating extracellular eNAMPT, as a novel biologic to suppress lung and systemic inflammatory cascades.
Cell Microsystems announced it has received two NIH Small Business Innovation and Research awards totaling $1.9M to automate CRISPR workflows using its proprietary CellRaft Technology.
Librede has been awarded a $1,490,000 Phase II Small Business Innovative Research Grant (SBIR) from the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), to further develop and scale their proprietary yeast-based cannabinoid production platform.
Somatic Cell Genome Editing aims to develop tools for safe and effective genome editing in humans.
Cell Microsystems Continues Momentum with $1.5M NIH Grant for Innovative Single-Cell RNA-Seq Platform
Cell Microsystems announced today it has been awarded a $1.5 million grant under the National Institutes of Health (NIH) SBIR program.
Results of the study were published today in The Lancet Infectious Diseases.
This grant will allow URMC to create an integrated multidisciplinary translational research program devoted to studying bone infections.
Akonni Biosystems Awarded NIH Grant to Support Commercialization of a Low-Cost, Simple, Rapid Point-of-Care Test for Tuberculosis and its Resistance to First-Line Drugs
This grant in particular will help Akonni accelerate the commercialization of its proprietary TruArray MDR-TB test on its TruDx 3000 sample-to-answer diagnostic platform.
Alkermes Calls for Impartial National Review of Scientific Data Supporting the Use of FDA-Approved Treatment Options for Opioid Dependence
The goal of this review should be to establish a shared national understanding of the characteristics of these medicines and the scientific and medical evidence supporting their use.
Researchers will use data gathered from the program to learn more about how individual differences in lifestyle, environment and biological makeup can influence health and disease.
Bioinformatics experts now view cloud-based computing and data storage as the most effective way to manage and use these rapidly growing biomedical datasets.
Seven Bridges today announced that it has been selected by the National Institutes of Health (NIH) to support the NIH Data Commons Pilot Phase.
PPD today announced it was awarded a seven-year contract under the Clinical Research Support Services program of the Division of AIDS, NIAID, part of the NIH.
Knopp Biosciences Announces Renewal of NIH Blueprint Grant Award for Advancing KCNQ2 Modulators in Epilepsy
Knopp Biosciences LLC today announced the renewal and expansion of its grant award from the National Institutes of Health Blueprint Neurotherapeutics Network to advance novel treatments for epilepsy.
Children's Hospital Los Angeles to Conduct Brain Imaging Research in Premature Babies to Identify Biomarkers Linked to Cognitive and Behavioral Disorders
Natasha Leporé, PhD, a principal investigator in the Department of Radiology and Imaging at Children's Hospital Los Angeles, has been awarded $1.7 million from the National Institute of Biomedical Imaging and Bioengineering of the NIH.
"Q" Bentley, a canine patient of Bush Veterinary Neurology Service (BVNS), has had a remarkable response to treatment of a glioma brain tumor. The treatment was performed through a clinical trial at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech, funded by the National Institutes of Health.